These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 19715758)

  • 1. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.
    Gibson GE; Starkov A; Blass JP; Ratan RR; Beal MF
    Biochim Biophys Acta; 2010 Jan; 1802(1):122-34. PubMed ID: 19715758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions in the mitochondrial enzyme α-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental?
    Chen H; Denton TT; Xu H; Calingasan N; Beal MF; Gibson GE
    J Neurochem; 2016 Dec; 139(5):823-838. PubMed ID: 27580471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases.
    Gibson GE; Huang HM
    J Bioenerg Biomembr; 2004 Aug; 36(4):335-40. PubMed ID: 15377868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration.
    Gibson GE; Blass JP; Beal MF; Bunik V
    Mol Neurobiol; 2005; 31(1-3):43-63. PubMed ID: 15953811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
    Singh A; Kukreti R; Saso L; Kukreti S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
    Tabassum R; Jeong NY
    Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The α-Ketoglutarate Dehydrogenase Complex as a Hub of Plasticity in Neurodegeneration and Regeneration.
    Hansen GE; Gibson GE
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation.
    Huang HM; Zhang H; Xu H; Gibson GE
    Biochim Biophys Acta; 2003 Jan; 1637(1):119-26. PubMed ID: 12527416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.
    Lai TS; Lin CJ; Wu YT; Wu CJ
    Front Biosci (Landmark Ed); 2017 Mar; 22(7):1114-1137. PubMed ID: 28199195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of enzyme deficiencies on mitochondrial energy metabolism and reactive oxygen species formation of neurons involved in rotenone-induced Parkinson's disease: a model-based analysis.
    Berndt N; Holzhütter HG; Bulik S
    FEBS J; 2013 Oct; 280(20):5080-93. PubMed ID: 23937586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of the α-ketoglutarate dehydrogenase inhibition for neuronal metabolism and survival: implications for neurodegenerative diseases.
    Trofimova LK; Araújo WL; Strokina AA; Fernie AR; Bettendorff L; Bunik VI
    Curr Med Chem; 2012; 19(34):5895-906. PubMed ID: 23061627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mitochondrial ROS in the brain: from physiology to neurodegeneration.
    Angelova PR; Abramov AY
    FEBS Lett; 2018 Mar; 592(5):692-702. PubMed ID: 29292494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.
    Jha SK; Jha NK; Kumar D; Ambasta RK; Kumar P
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1132-1146. PubMed ID: 27345267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dynamics, a key executioner in neurodegenerative diseases.
    Panchal K; Tiwari AK
    Mitochondrion; 2019 Jul; 47():151-173. PubMed ID: 30408594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
    Wu Y; Chen M; Jiang J
    Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological disorders and mitochondria.
    Cabral-Costa JV; Kowaltowski AJ
    Mol Aspects Med; 2020 Feb; 71():100826. PubMed ID: 31630771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.